Extract
We read with interest the article by Lewis et al. [1], which reports an increased mortality in patients with idiopathic pulmonary arterial hypertension (IPAH) and mild impairment in computed tomography (CT). They also show that low diffusing capacity of the lung for carbon monoxide (DLCO) was associated with worse outcomes. It is an important paper pointing out interesting issues on which we would like to comment.
Abstract
PAH patients with mild parenchymal disease/low DLCO should be considered as group 3 patients with pulmonary vascular phenotype https://bit.ly/33awS0J
Acknowledgements
This article was written on behalf of the PHAROS Clinical Research Collaboration members.
Footnotes
Conflict of interest: L. Godinas has nothing to disclose.
Conflict of interest: S. Harari has nothing to disclose.
Conflict of interest: J.A. Barberà has nothing to disclose.
Conflict of interest: D. Montani reports grants and personal fees from Actelion and Bayer, personal fees from GSK, Pfizer, Chiesi and Boehringer, grants, personal fees and non-financial support from MSD, non-financial support from Acceleron, outside the submitted work.
- Received September 17, 2020.
- Accepted September 18, 2020.
- Copyright ©ERS 2020